AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 292: F804-F811, 2007. First published October 10, 2006; doi:10.1152/ajprenal.00258.2006
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/F804    most recent
00258.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, C.
Right arrow Articles by Bucher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, C.
Right arrow Articles by Bucher, M.

Regulation of renal glucose transporters during severe inflammation

Christoph Schmidt,1 Klaus Höcherl,2 and Michael Bucher1

Departments of 1Anesthesiology and 2Pharmacology, Regensburg University, Regensburg, Germany

Submitted 10 July 2006 ; accepted in final form 5 October 2006

Severe sepsis is accompanied by acute renal failure (ARF) with renal tubular dysfunction and glucosuria. In this study, we aimed to determine the regulation of renal tubular glucose transporters during severe experimental inflammation. Male C57BL/6J mice were injected with LPS or proinflammatory cytokines, and renal perfusion, glomerular filtration rate (GFR), fractional glucose excretion, and expression of tubular glucose transporters were determined. We found a decreased plasma glucose concentration with impaired renal tissue perfusion and GFR and increased fractional glucose excretion associated with decreased expression of SGLT2, SGLT3, and GLUT2 after LPS injection. Similar alterations were observed after application of TNF-{alpha}, IL-1beta, IL-6, or IFN-{gamma}. To clarify the role of proinflammatory cytokines, we performed LPS injections in knockout mice with deficiencies for TNF-{alpha}, IL-1 receptor type 1, IFN-{gamma}, or IL-6 as well as LPS injections in glucocorticoid-treated wild-type mice. LPS-induced alterations of glucose transporters also were present in single-cytokine knockout mice. In contrast, glucocorticoid treatment clearly attenuated LPS-induced changes in renal glucose transporter expression and improved GFR and fractional glucose excretion. LPS-induced decrease of renal perfusion was not improved by glucocorticoids, indicating a minor role of ischemia in the development of septic renal dysfunction. Our results demonstrate modifications of tubular glucose transporters during severe inflammation that are probably mediated by proinflammatory cytokines and account for the development of ARF with increased fractional glucose excretion. In addition, our findings provide an explanation why single anti-cytokine strategies fail in the therapy of septic patients and contribute to an understanding of the beneficial effects of glucocorticoids on septic renal dysfunction.

sepsis; acute renal failure; tubular function; lipopolysaccharide; cytokines; glucocorticoids



Address for reprint requests and other correspondence: M. Bucher, Dept. of Anesthesiology, Regensburg Univ., 93042 Regensburg, Germany (e-mail: michael.bucher{at}klinik.uni-regensburg.de)




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Kekuda, P. Saha, and U. Sundaram
Role of Sp1 and HNF1 transcription factors in SGLT1 regulation during chronic intestinal inflammation
Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1354 - G1361.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. L. Mehta
Glycemic Control and Critical Illness: Is the Kidney Involved?
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2623 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. J. Lee, J. S. Heo, H. N. Suh, M. Y. Lee, and H. J. Han
Interleukin-6 stimulates {alpha}-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-{kappa}B
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1036 - F1046.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
V. Petrovic, S. Teng, and M. Piquette-Miller
REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION
Mol. Interv., April 1, 2007; 7(2): 99 - 111.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.